| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 22:02:44 UTC |
|---|
| Update Date | 2021-09-26 23:17:01 UTC |
|---|
| HMDB ID | HMDB0259461 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea |
|---|
| Description | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea belongs to the class of organic compounds known as n-acylpiperidines. N-acylpiperidines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of a piperidine. Based on a literature review very few articles have been published on 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea. This compound has been identified in human blood as reported by (PMID: 31557052 ). 1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC(=O)N1CCC(CC1)NC(=O)NC12CC3CC(CC(C3)C1)C2 InChI=1S/C18H29N3O2/c1-12(22)21-4-2-16(3-5-21)19-17(23)20-18-9-13-6-14(10-18)8-15(7-13)11-18/h13-16H,2-11H2,1H3,(H2,19,20,23) |
|---|
| Synonyms | | Value | Source |
|---|
| N'-(1-acetylpiperidin-4-yl)-N-(adamantan-1-yl)carbamimidate | HMDB | | 1-(1-Acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea | HMDB |
|
|---|
| Chemical Formula | C18H29N3O2 |
|---|
| Average Molecular Weight | 319.449 |
|---|
| Monoisotopic Molecular Weight | 319.225977186 |
|---|
| IUPAC Name | 3-(1-acetylpiperidin-4-yl)-1-(adamantan-1-yl)urea |
|---|
| Traditional Name | 3-(1-acetylpiperidin-4-yl)-1-(adamantan-1-yl)urea |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(=O)N1CCC(CC1)NC(=O)NC12CC3CC(CC(C3)C1)C2 |
|---|
| InChI Identifier | InChI=1S/C18H29N3O2/c1-12(22)21-4-2-16(3-5-21)19-17(23)20-18-9-13-6-14(10-18)8-15(7-13)11-18/h13-16H,2-11H2,1H3,(H2,19,20,23) |
|---|
| InChI Key | HUDQLWBKJOMXSZ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as n-acylpiperidines. N-acylpiperidines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of a piperidine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Piperidines |
|---|
| Sub Class | N-acylpiperidines |
|---|
| Direct Parent | N-acylpiperidines |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-acyl-piperidine
- Acetamide
- Tertiary carboxylic acid amide
- Urea
- Carboxamide group
- Azacycle
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.74 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.4029 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.97 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1372.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 180.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 163.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 167.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 126.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 287.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 362.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 571.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 749.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 321.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1136.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 210.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 247.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 570.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 383.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 264.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TMS,isomer #1 | CC(=O)N1CCC(N(C(=O)NC23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)CC1 | 2945.5 | Semi standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TMS,isomer #1 | CC(=O)N1CCC(N(C(=O)NC23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)CC1 | 2566.9 | Standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TMS,isomer #1 | CC(=O)N1CCC(N(C(=O)NC23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)CC1 | 3437.5 | Standard polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TMS,isomer #2 | CC(=O)N1CCC(NC(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)CC1 | 2901.1 | Semi standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TMS,isomer #2 | CC(=O)N1CCC(NC(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)CC1 | 2584.1 | Standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TMS,isomer #2 | CC(=O)N1CCC(NC(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)CC1 | 3511.0 | Standard polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,2TMS,isomer #1 | CC(=O)N1CCC(N(C(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)[Si](C)(C)C)CC1 | 2833.5 | Semi standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,2TMS,isomer #1 | CC(=O)N1CCC(N(C(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)[Si](C)(C)C)CC1 | 2715.5 | Standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,2TMS,isomer #1 | CC(=O)N1CCC(N(C(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C)[Si](C)(C)C)CC1 | 3386.7 | Standard polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TBDMS,isomer #1 | CC(=O)N1CCC(N(C(=O)NC23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)CC1 | 3156.6 | Semi standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TBDMS,isomer #1 | CC(=O)N1CCC(N(C(=O)NC23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)CC1 | 2828.6 | Standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TBDMS,isomer #1 | CC(=O)N1CCC(N(C(=O)NC23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)CC1 | 3550.1 | Standard polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TBDMS,isomer #2 | CC(=O)N1CCC(NC(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)CC1 | 3128.6 | Semi standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TBDMS,isomer #2 | CC(=O)N1CCC(NC(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)CC1 | 2854.8 | Standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,1TBDMS,isomer #2 | CC(=O)N1CCC(NC(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)CC1 | 3608.9 | Standard polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,2TBDMS,isomer #1 | CC(=O)N1CCC(N(C(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC1 | 3336.2 | Semi standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,2TBDMS,isomer #1 | CC(=O)N1CCC(N(C(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC1 | 3140.4 | Standard non polar | 33892256 | | 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea,2TBDMS,isomer #1 | CC(=O)N1CCC(N(C(=O)N(C23CC4CC(CC(C4)C2)C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC1 | 3528.3 | Standard polar | 33892256 |
|
|---|